Over the last year, genomics data has become one of the most powerful tools in Canada’s arsenal against COVID-19. As we mark the first anniversary of the Canadian COVID-19 Genomics Network (CanCOGeN), learn more about how this groundbreaking pan-Canadian initiative has met the pandemic challenge head on – from informing public health decision-making, to mobilizing a rapid response to new variants of concern, to improving Canada’s preparedness for future pandemics and public health challenges.
First COVID-19 case in Canada
First SARS-CoV-2 genomes sequenced in Canada
- World Health Organization declares COVID-19 a global pandemic.
- Community transmission of SARS-CoV-2 confirmed in Canada.
- Genome Canada leads in proposing new national viral genomics network.
Canadian COVID-19 Genomics Network (CanCOGeN) launches with $40M federal investment
Canada passes 10k total COVID-19 cases.
CanCOGeN partners with COVID-19 Genomics UK Consortium
HostSeq and VirusSeq implementation Committees launch.
CanCOGeN-HostSeq Research Ethics Board approval enables patient recruitment to begin
- Canada passes 100K total COVID-19 cases.
- Dr. Catalina Lopez-Correa joins CanCOGeN as Executive Director.
First HostSeq study begins
VirusSeq members lead international team in publishing a SARS-CoV-2 data standard
- HostSeq Sequencing begins.
- VirusSeq establishes national quality. assurance/quality control criteria, now used in many countries.
- 10K viral sequences completed.
Variant of concern (B.1.1.7) emerges in the U.K.
Variant of concern (B.1.351) emerges in South Africa
Approval of first COVID-19 vaccine in Canada
- Variant of concern (B.1.1.248 (P.1)) emerges in Brazil.
- First COVID-19 vaccine administered in Canada.
- Canada passes 500K total COVID-19 cases.
- CanCOGeN mobilizes within hours of reports that a new SARS-CoV-2 variant is spreading in the U.K.
- First variant of concern case detected in Canada (B.1.1.7).
CanCOGeN partners to support the Government of Canada Variants of Concern Strategy to track fast-spreading SARS-CoV-2 variants
- 50K viral sequences completed.
- 1K host sequences completed.
20K viral sequences shared on GISAID
Canada passes 1M total COVID-19 cases
- HostSeq has received 4K samples and sequenced 2K host genomes.
- Canadian VirusSeq Data Portal launched.
- 80K viral sequences completed.